$4.25
arrow_drop_down3.18%Key Stats | |
---|---|
Open | $4.41 |
Prev. Close | $4.39 |
EPS | 0.85 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $56.82M |
LOW | HIGH | |
---|---|---|
Day Range | 4.13 | 4.41 |
52 Week Range | 3.21 | 17.54 |
Ratios | |
---|---|
Revenue | - |
EPS | 0.85 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K
Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio
Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City
Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q